Report #2871640

Received Nov 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: MI
Recovered: Unknown
Vaccinated: Nov 5, 2025
Onset: Nov 5, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	3EG9B	—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

Inappropriate Schedule of Vaccine - Early second dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 79-year-old male patient who received Herpes zoster (Shingrix) (batch number 3EG9B, expiry date 02-MAY-2027) for prophylaxis. Concomitant products included Varicella zoster vaccine rgE (CHO) (Shingrix). On 05-NOV-2025, the patient received the 2nd dose of Shingrix. On 05-NOV-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: Inappropriate Schedule of Vaccine - Early second dose). The outcome of the drug dose administration interval too short was not applicable. Additional Information: GSK receipt date: 05-NOV-2025 The reporter called from a pharmacy to report that a Shingrix vaccine was given early to a patient, how did they proceed. Vaccination dates (for both first and second dose), vaccine detail (for second dose) and patient demographics were obtained in this call. No further information was obtained in this call.